GlassScriptPhysician profile
Angie E Wen
NPI 1114048642
$2,573.62
in general payments reported to CMS, 2019-2025
22 companies · $891 in 2025
The $891 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $142 · 2021: $64.92 · 2022: $135 · 2023: $551 · 2024: $517 · 2025: $891.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,959.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $479.56 | 2022-2025 | Centurion, Clareon, Rocklatan |
| Tarsus Pharmaceuticals, INC. | $376.14 | 2024-2025 | Xdemvy |
| Bausch & Lomb Americas INC. | $232.93 | 2023-2025 | Xipere, Miebo, Vyzulta |
| Abbvie INC. | $226.05 | 2022-2025 | Lumigan, Alphagan P, Vuity |
| Oyster Point Pharma, INC. | $152.19 | 2022-2025 | Tyrvaya, Ryzumvi |
| Harrow Eye, LLC | $120.22 | 2024-2025 | Vevye |
| Optinose US, INC. | $119.56 | 2019 | |
| Omeros Corporation | $118.37 | 2019 | |
| Biotissue Holdings INC. | $115.98 | 2023 | |
| Amgen INC. | $102.43 | 2024-2025 | Tepezza |
| New World Medical,INC. | $101.41 | 2020 | |
| Sun Pharmaceutical Industries INC. | $99.73 | 2019-2025 | Cequa |
| Carl Zeiss Meditec, INC. | $75.36 | 2024 | |
| Novartis Pharmaceuticals Corporation | $55.21 | 2021-2022 | |
| Dompe US, INC. | $46.62 | 2024-2025 | Oxervate |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ocular Therapeutix, INC. | $30.48 | 2021-2022 | |
| Rxsight INC | $29.59 | 2025 | Light Adjustable Lens (Lal), Rxsight Injector Cartridge, Rxsight Injector Handpiece |
| Sight Sciences, INC. | $25.02 | 2023 | Tearcare System |
| Eyevance Pharmaceuticals LLC | $20.97 | 2020 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $15.32 | 2021 | |
| Allergan, INC. | $11.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Angie Wen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.